{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:03:32Z","timestamp":1792710212027,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":2968,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1074\/jbc.m112.351056","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T04:30:35Z","timestamp":1341635435000},"page":"28386-28397","source":"Crossref","is-referenced-by-count":34,"title":["\u03b1-Galactosidase Aggregation Is a Determinant of Pharmacological Chaperone Efficacy on Fabry Disease Mutants"],"prefix":"10.1016","volume":"287","author":[{"given":"Aleksandra","family":"Siekierska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"De Baets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joke","family":"Reumers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Rudyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerensa","family":"Broersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Couceiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Van Durme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Schymkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M112.351056_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease: ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1074\/jbc.M112.351056_bib2","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","article-title":"\u03b1-Galactosidase A-deficient mice: a model of Fabry disease","volume":"94","author":"Ohshima","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.351056_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.1380030204","article-title":"Molecular basis of Fabry disease: mutations and polymorphisms in the human \u03b1-galactosidase A gene","volume":"3","author":"Eng","year":"1994","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M112.351056_bib4","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/S0021-9258(18)61618-7","article-title":"Synthesis and processing of \u03b1-galactosidase A in human fibroblasts: evidence for different mutations in Fabry disease","volume":"262","author":"Lemansky","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M112.351056_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jmb.2004.01.035","article-title":"The molecular defect leading to Fabry disease: structure of human \u03b1-galactosidase","volume":"337","author":"Garman","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.M112.351056_bib6","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1074\/jbc.M112.351056_bib7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/318809","article-title":"A phase 1\/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies","volume":"68","author":"Eng","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1074\/jbc.M112.351056_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1074\/jbc.M112.351056_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1096\/fj.04-2375com","article-title":"A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder","volume":"19","author":"Yam","year":"2005","journal-title":"FASEB J."},{"key":"10.1074\/jbc.M112.351056_bib10","doi-asserted-by":"crossref","first-page":"C1076","DOI":"10.1152\/ajpcell.00426.2005","article-title":"Pharmacological chaperone corrects lysosomal storage in Fabry disease caused by trafficking-incompetent variants","volume":"290","author":"Yam","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1074\/jbc.M112.351056_bib11","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1111\/j.1742-4658.2007.06041.x","article-title":"Active-site-specific chaperone therapy for Fabry disease: yin and yang of enzyme inhibitors","volume":"274","author":"Fan","year":"2007","journal-title":"FEBS J."},{"key":"10.1074\/jbc.M112.351056_bib12","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and iminosugar pharmacological chaperones on lysosomal glycosidase structure and stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.M112.351056_bib13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s10545-009-1077-0","article-title":"The pharmacological chaperone 1-deoxygalactonojirimycin increases \u03b1-galactosidase A levels in Fabry patient cell lines","volume":"32","author":"Benjamin","year":"2009","journal-title":"J. Inher. Metab. Dis."},{"key":"10.1074\/jbc.M112.351056_bib14","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1007\/s10038-008-0316-9","article-title":"Structural characterization of mutant \u03b1-galactosidases causing Fabry disease","volume":"53","author":"Sugawara","year":"2008","journal-title":"J. Hum. Genet."},{"key":"10.1074\/jbc.M112.351056_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00439-005-1300-5","article-title":"Fabry disease: correlation between structural changes in \u03b1-galactosidase, and clinical and biochemical phenotypes","volume":"117","author":"Matsuzawa","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1074\/jbc.M112.351056_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/FPC.0b013e32830500f4","article-title":"Prediction of response of mutated \u03b1-galactosidase A to a pharmacological chaperone","volume":"18","author":"Shin","year":"2008","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1074\/jbc.M112.351056_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1750-1172-5-36","article-title":"Prediction of the responsiveness to pharmacological chaperones: lysosomal human \u03b1-galactosidase, a case of study","volume":"5","author":"Andreotti","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1074\/jbc.M112.351056_bib18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1750-1172-6-66","article-title":"Therapy of Fabry disease with pharmacological chaperones: from in silico predictions to in vitro tests","volume":"6","author":"Andreotti","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1074\/jbc.M112.351056_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbrc.2007.06.048","article-title":"4-Phenylbutyrate rescues trafficking incompetent mutant \u03b1-galactosidase A without restoring its functionality","volume":"360","author":"Yam","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.M112.351056_bib20","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1006\/bbrc.1996.0486","article-title":"Aggregation of the inactive form of human \u03b1-galactosidase in the endoplasmic reticulum","volume":"220","author":"Ishii","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.M112.351056_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/humu.20905","article-title":"Protein sequences encode safeguards against aggregation","volume":"30","author":"Reumers","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M112.351056_bib22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1146\/annurev.biochem.052308.114844","article-title":"Biological and chemical approaches to diseases of proteostasis deficiency","volume":"78","author":"Powers","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1074\/jbc.M112.351056_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"10.1074\/jbc.M112.351056_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ceb.2010.11.002","article-title":"Chemical and\/or biological therapeutic strategies to ameliorate protein misfolding diseases","volume":"23","author":"Ong","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1074\/jbc.M112.351056_bib25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nbt1012","article-title":"Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins","volume":"22","author":"Fernandez-Escamilla","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1074\/jbc.M112.351056_bib26","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1074\/jbc.M112.351056_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA: a self-parameterizing force field","volume":"47","author":"Krieger","year":"2002","journal-title":"Proteins"},{"key":"10.1074\/jbc.M112.351056_bib28","doi-asserted-by":"crossref","first-page":"D935","DOI":"10.1093\/nar\/gkr996","article-title":"SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants","volume":"40","author":"De Baets","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1074\/jbc.M112.351056_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0009-8981(81)90384-3","article-title":"Differential assay for lysosomal \u03b1-galactosidases in human tissues and its application to Fabry's disease","volume":"112","author":"Mayes","year":"1981","journal-title":"Clin. Chim. Acta"},{"key":"10.1074\/jbc.M112.351056_bib30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/humu.20671","article-title":"Annotating single amino acid polymorphisms in the UniProt\/Swiss-Prot knowledgebase","volume":"29","author":"Yip","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1074\/jbc.M112.351056_bib31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jmb.2005.11.035","article-title":"How evolutionary pressure against protein aggregation shaped chaperone specificity","volume":"355","author":"Rousseau","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1074\/jbc.M112.351056_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbadis.2008.03.001","article-title":"Rescue of mutant \u03b1-galactosidase A in the endoplasmic reticulum by 1-deoxygalactonojirimycin leads to trafficking to lysosomes","volume":"1782","author":"Hamanaka","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M112.351056_bib33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7164\/antibiotics.21.160","article-title":"Antiviral activity of brefeldin A and verrucarin A","volume":"21","author":"Tamura","year":"1968","journal-title":"J. Antibiot."},{"key":"10.1074\/jbc.M112.351056_bib34","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.116.5.1071","article-title":"Brefeldin A: insights into the control of membrane traffic and organelle structure","volume":"116","author":"Klausner","year":"1992","journal-title":"J. Cell Biol."},{"key":"10.1074\/jbc.M112.351056_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1074\/jbc.M112.351056_bib36","first-page":"87","article-title":"Update on treatment of lysosomal storage disease","volume":"26","author":"Bruni","year":"2007","journal-title":"Acta Myol."},{"key":"10.1074\/jbc.M112.351056_bib37","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1046\/j.1432-1327.2000.01457.x","article-title":"In vitro inhibition and intracellular enhancement of lysosomal \u03b1-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives","volume":"267","author":"Asano","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1074\/jbc.M112.351056_bib38","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in GM1-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.351056_bib39","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1074\/jbc.M112.351056_bib40","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","article-title":"Therapeutic strategies to ameliorate lysosomal storage disorders: a focus on Gaucher disease","volume":"63","author":"Sawkar","year":"2006","journal-title":"Cell Mol. Life Sci."},{"key":"10.1074\/jbc.M112.351056_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"10.1074\/jbc.M112.351056_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"Schiffmann","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1074\/jbc.M112.351056_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1096-7192(02)00151-8","article-title":"Structural basis of Fabry disease","volume":"77","author":"Garman","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1074\/jbc.M112.351056_bib44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/jhg.2009.32","article-title":"Structural modeling of mutant \u03b1-glucosidases resulting in a processing\/transport defect in Pompe disease","volume":"54","author":"Sugawara","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1074\/jbc.M112.351056_bib45","doi-asserted-by":"crossref","first-page":"10118","DOI":"10.1073\/pnas.96.18.10118","article-title":"The propagation of binding interactions to remote sites in proteins: analysis of the binding of the monoclonal antibody D1.3 to lysozyme","volume":"96","author":"Freire","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M112.351056_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1472-6807-8-43","article-title":"Quantifying information transfer by protein domains: analysis of the Fyn SH2 domain structure","volume":"8","author":"Lenaerts","year":"2008","journal-title":"BMC Struct. Biol."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820683776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820683776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M112.351056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T11:16:21Z","timestamp":1641381381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820683776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":46,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0021925820683776"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m112.351056","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}